Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $17.0400 (3.02%) ($16.4500 - $17.0500) on Fri. Feb. 15, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.96% (three month average) | RSI | 73 | Latest Price | $17.0400(3.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.9% a day on average for past five trading days. | Weekly Trend | HALO advances 1.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(55%) IWO(55%) XBI(51%) IWM(50%) ARKG(49%) | Factors Impacting HALO price | HALO will decline at least -1.48% in a week (0% probabilities). VXX(-14%) UUP(-14%) VIXM(-6%) TLT(-5%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.48% (StdDev 2.96%) | Hourly BBV | 0 () | Intraday Trend | 2.3% | | | |
|
5 Day Moving Average | $16.64(2.4%) | 10 Day Moving Average | $16.61(2.59%) | 20 Day Moving Average | $16.36(4.16%) | To recent high | 0% | To recent low | 27.8% | Market Cap | $2.329b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |